Cite

    Amedro, P., Gavotto, A., Abassi, H., Picot, M., Matecki, S., Malekzadeh‐Milani, S., Levy, M., Ladouceur, M., Ovaert, C., Aldebert, P., Thambo, J., Fraisse, A., Humbert, M., Cohen, S., Baruteau, A., Karsenty, C., Bonnet, D., Hascoet, S., & ,  (2020). efficacy of phosphodiesterase type 5 inhibitors in univentricular congenital heart disease: the SV‐INHIBITION study design. ESC heart failure, 7, 747–756. http://access.bl.uk/ark:/81055/vdc_100103628677.0x00000e